Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arotinolol hydrochloride for essential hypertension in younger and middle-aged adults
ChiCTR2100049628Phase 4Not yet recruiting
- Sponsor
- First Hospital of China Medical University
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of arotinolol, metoprolol and atenolol in essential hypertension (3 arms), sponsored by First Hospital of China Medical University. Primary endpoint: Blood pressure. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
arotinololmetoprololatenolol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR2100049628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049628.